Curis Lifesciences IPO GMP: Day 1 IPO Live Updates

Click & Sign Up to Get Latest Updates on Curis Lifesciences IPO

The Curis Lifesciences IPO GMP is ₹7.5 as of 7th November 2025. It is a book-building IPO of ₹27.52 crore, comprising a fresh issue of 22,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 14th November 2025. The face value of Curis Lifesciences shares is ₹10 per share, and the IPO price band is set at ₹120 to ₹128 per share. Retail investors can bid for a minimum of 2 lots of 67 shares, worth ₹14,807.

Curis Lifesciences IPO Grey Market Premium

As of 7th November 2025, the GMP for the Curis Lifesciences IPO stands at ₹7.5 per share. Thus, the estimated listing price would be ₹135.5. This indicates that the estimated listing gain in this IPO could be 5.86%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for GMP updates on the Curis Lifesciences IPO.

Curis Lifesciences IPO Details

Explanation

Curis Lifesciences IPO: Curis Lifesciences Limited has announced the issue price of ₹120 to ₹128 per share. With this IPO, the company allows retail investors to bid for two lots of 2,000 shares worth ₹2,56,000. The face value of Curis Lifesciences Limited shares is ₹10 per share. The shares of Curis Lifesciences Limited will be listed on NSE and SME on its tentative listing day, 14th November 2025. Scroll down to view GMP updates and reviews of the Curis Lifesciences IPO. 

Objectives of the Curis Lifesciences IPO

The primary objective of the Curis Lifesciences IPO is to raise ₹27.52 crore. However, before applying for the IPO, it is essential to be aware of its secondary objectives. Explore them below

• Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities.
• Capital Expenditure towards Construction of a Storage Facility
• Pre-payment/Repayment of outstanding Secured Loans
• Product Registrations in other countries
• Funding our Working Capital Requirements
• General Corporate Purposes

Curis Lifesciences IPO Registrar

According to recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Curis Lifesciences IPO GMP, allotment, and refund, you can contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in or +91-22-4918 6270.

Curis Lifesciences IPO Review  

The Curis Lifesciences IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Curis Lifesciences Limited’s revenue increased by 38% from ₹4.87 crore in March 2024 to ₹ 6.49 crore in March 2025. Moreover, the company’s PAT increased by 25% from ₹4.87 crores to ₹6.11  crores. Investors can analyse other relevant factors and make a decision accordingly. Investors can analyse pertinent other factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Curis Lifesciences IPO or not.

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Curis Lifesciences IPO.

The P/E ratio of Curis Lifesciences Limited’s shares is 12.44, and its Earnings Per Share (EPS) is 10.29. Thus, the Curis Lifesciences Limited IPO can deliver gains on its tentative listing day, 14th November 2025

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Mittal Solutions Limited are subject to change following the IPO. Refer to the table below for post-issue updates on these two metrics. 

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

FAQs on Curis Lifesciences IPO

What is the GMP of the Curis Lifesciences IPO?

Ans. As of 7th November 2025, the Curis Lifesciences (Grey Market Premium) stands at ₹7.5. This suggests that the estimated listing price could be 5.86% of the share price.

What is the issue price of the Curis Lifesciences IPO?

Ans. The Curis Lifesciences IPO price range is ₹120.00 to ₹128.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,000 shares, worth ₹2,56,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth ₹3,84,000.

Who is the registrar of the Curis Lifesciences IPO?

According to recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Curis Lifesciences IPO GMP, allotment, and refund, you can contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in or +91-22-4918 6270.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Curis Lifesciences IPO, download the Curis Lifesciences IPO RHP and Curis Lifesciences IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Recent Articles

Top 10 Penny Stocks in India  | Penny Stocks to Buy in 2025

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Accelerator IPO GMP & Review: Apply or Avoid?

VigourPlast India IPO Listing Preview: What to Expect Now?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates